These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 8339257)
21. Effects of N-(phosphonacetyl)-L-aspartate on murine tumors and normal tissues in vivo and in vitro and the relationship of sensitivity to rate of proliferation and level of aspartate transcarbamylase. Johnson RK; Swyryd EA; Stark GR Cancer Res; 1978 Feb; 38(2):371-8. PubMed ID: 620408 [No Abstract] [Full Text] [Related]
22. Modulation of the antitumour activity of cisplatin alone and in combination with 5-fluoro-2'-deoxyuridine by N-phosphonacetyl-L-aspartate in murine colon carcinoma no. 26. Van Laar JA; Mayhew EG; Cao S; Durrani FA; Peters GJ; Rustum YM Eur J Cancer; 1995 Jun; 31A(6):974-6. PubMed ID: 7646931 [TBL] [Abstract][Full Text] [Related]
23. Plasma uridine changes in cancer patients treated with the combination of dipyridamole and N-phosphonacetyl-L-aspartate. Chan TC; Markman M; Cleary S; Howell SB Cancer Res; 1986 Jun; 46(6):3168-72. PubMed ID: 3698032 [TBL] [Abstract][Full Text] [Related]
24. Phase II studies of single-agent cimetidine and the combination N-phosphonacetyl-L-aspartate (NSC-224131) plus L-alanosine (NSC-153353) in advanced malignant melanoma. Morton RF; Creagan ET; Cullinan SA; Mailliard JA; Ebbert L; Veeder MH; Chang M J Clin Oncol; 1987 Jul; 5(7):1078-82. PubMed ID: 3598611 [TBL] [Abstract][Full Text] [Related]
25. Antitumor activity of the weekly intravenous push schedule of 5-fluoro-2'-deoxyuridine +/- N-phosphonacetyl-L-aspartate in mice bearing advanced colon carcinoma 26. van Laar JA; Durrani FA; Rustum YM Cancer Res; 1993 Apr; 53(7):1560-4. PubMed ID: 8453623 [TBL] [Abstract][Full Text] [Related]
26. 5-Iododeoxyuridine increases the efficacy of the radioimmunotherapy of human tumors growing in nude mice. Santos O; Pant KD; Blank EW; Ceriani RL J Nucl Med; 1992 Aug; 33(8):1530-4. PubMed ID: 1634946 [TBL] [Abstract][Full Text] [Related]
27. Role of thymidine in biochemical modulation: a review. O'Dwyer PJ; King SA; Hoth DF; Leyland-Jones B Cancer Res; 1987 Aug; 47(15):3911-9. PubMed ID: 3300957 [TBL] [Abstract][Full Text] [Related]
28. Effect of 6-aminonicotinamide on the pentose phosphate pathway: 31P NMR and tumor growth delay studies. Koutcher JA; Alfieri AA; Matei C; Meyer KL; Street JC; Martin DS Magn Reson Med; 1996 Dec; 36(6):887-92. PubMed ID: 8946354 [TBL] [Abstract][Full Text] [Related]
29. Biochemical modulation: a modality that has come of therapeutic age. Allegra CJ J Clin Oncol; 1991 Oct; 9(10):1723-6. PubMed ID: 1919622 [No Abstract] [Full Text] [Related]
30. Five-chlorodeoxycytidine and biomodulators of its metabolism result in fifty to eighty percent cures of advanced EMT-6 tumors when used with fractionated radiation. Greer S; Schwade J; Marion HS Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1059-69. PubMed ID: 7607927 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic synergism of tiazofurin and selected antitumor drugs against sensitive and resistant P388 leukemia in mice. Harrison SD; O'Dwyer PJ; Trader MW Cancer Res; 1986 Jul; 46(7):3396-400. PubMed ID: 3708573 [TBL] [Abstract][Full Text] [Related]
32. Improved therapeutic index with sequential N-phosphonacetyl-L-aspartate plus high-dose methotrexate plus high-dose 5-fluorouracil and appropriate rescue. Martin DS; Stolfi RL; Sawyer RC; Spiegelman S; Young CW Cancer Res; 1983 Oct; 43(10):4653-61. PubMed ID: 6603903 [TBL] [Abstract][Full Text] [Related]
33. Failure of L-histidinol to improve the therapeutic efficiency of 5-fluorouracil against murine breast tumors. Stolfi RL; Sawyer RC; Martin DS Cancer Res; 1987 Jan; 47(1):16-20. PubMed ID: 3791203 [TBL] [Abstract][Full Text] [Related]
34. The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow. Koutcher JA; Motwani M; Zakian KL; Li XK; Matei C; Dyke JP; Ballon D; Yoo HH; Schwartz GK Clin Cancer Res; 2000 Apr; 6(4):1498-507. PubMed ID: 10778982 [TBL] [Abstract][Full Text] [Related]
35. 5-chlorodeoxycytidine, a radiosensitizer effective against RIF-1 and Lewis lung carcinoma, is also effective against a DMBA-induced mammary adenocarcinoma and the EMT-6 tumor in BALB/c mice. Greer S; Santos O; Gottlieb C; Schwade J; Marion HS Int J Radiat Oncol Biol Phys; 1992; 22(3):505-10. PubMed ID: 1735688 [TBL] [Abstract][Full Text] [Related]
36. Effect of modulators on 5-fluorouracil metabolite patterns in murine colon carcinoma determined by in vitro 19F nuclear magnetic resonance spectroscopy. Kamm VJ; Rietjens IM; Vervoort J; Heerschap A; Rosenbusch G; Hofs HP; Wagener DJ Cancer Res; 1994 Aug; 54(16):4321-6. PubMed ID: 8044779 [TBL] [Abstract][Full Text] [Related]
37. N-(phosphonacetyl)-L-aspartate synergistically enhances the cytotoxicity of 5-fluorouracil/interferon-alpha-2a against human colon cancer cell lines. Wadler S; Mao X; Bajaj R; Hallam S; Schwartz EL Mol Pharmacol; 1993 Nov; 44(5):1070-6. PubMed ID: 8246910 [TBL] [Abstract][Full Text] [Related]
38. MTA (LY231514) in combination treatment regimens using human tumor xenografts and the EMT-6 murine mammary carcinoma. Teicher BA; Alvarez E; Liu P; Lu K; Menon K; Dempsey J; Schultz RM Semin Oncol; 1999 Apr; 26(2 Suppl 6):55-62. PubMed ID: 10598556 [TBL] [Abstract][Full Text] [Related]
39. Concentrations of N-(phosphonacetyl)-L-aspartate (PALA) in plasma and tears in man. Lankelma J; Penders PG; Leyva A; Kleeberg UR; Kenny JB; Bramwell V; McVie JG; Pinedo HM Eur J Cancer Clin Oncol; 1981 Nov; 17(11):1199-204. PubMed ID: 7199467 [No Abstract] [Full Text] [Related]
40. Selective inhibition of pyrimidine synthesis and depletion of nucleotide pools by N-(phosphonacetyl)-L-aspartate. Moyer JD; Handschumacher RE Cancer Res; 1979 Aug; 39(8):3089-94. PubMed ID: 455293 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]